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ABSTRACT
Background: Late diagnosis of lung cancer can
impact on survival rates. Patients delay seeking help
for a number of reasons. This study explored symptom
appraisal and help-seeking decisions among patients
referred to specialist respiratory services with
symptoms suggestive of lung cancer.
Methods: In-depth qualitative interviews with patients
as soon as possible after referral, ideally before
diagnosis and mainly within 10 weeks, explored factors
impacting on their pathways prior to referral.
Framework analysis, underpinned by the Model of
Pathways to Treatment, was used to explore the data
with particular focus on patients’ beliefs and
experiences, disease factors and healthcare
professional influences.
Results: 35 patients were interviewed (aged
41–88 years, 15 women, 17 with lung cancer).
All described similar presenting symptoms and triggers
to seek help. Appraisal of symptoms was influenced by
whether they had a lung comorbidity; seriousness of
symptoms was interpreted within the context of
previous illness experiences. Help-seeking was triggered
when: symptoms failed to respond as expected; there
was an increased awareness of symptoms of lung
cancer; the public nature of a cough meant others were
able to endorse help-seeking. Almost half visited the
general practitioner (GP) two or more times before
referral; during this period they reinterpreted initial
symptoms and appraised new symptoms. The meaning
given to symptoms changed over time and many
became increasingly concerned they may have lung
cancer. The GP played a role in ensuring timely further
help-seeking but often there was little guidance on how
to monitor symptoms or when to reconsult.
Conclusions: Patients diagnosed with and without
lung cancer had similar symptom pathways. Findings
provide guidance for lung cancer awareness campaigns
on the importance of social networks in endorsing
patient help-seeking. The importance of appropriate
advice, monitoring and safety-netting procedures by
GPs for people presenting with symptoms suggestive of
lung cancer is also highlighted.
INTRODUCTION
Lung cancer is the most common cause of
cancer death in the UK. While there has
been a fall in incidence in men, there has
been a slow, steady increase of cases in
women. It continues to have one of the
poorest 5-year relative survival rates of all
cancers,1 only 7.8% for men and 9.3% for
women.2 Most cases of lung cancer present
symptomatically, and poor survival rates are
primarily due to later stage disease, the
biology of the disease, lack of screening and
fewer treatment options.3 4 Diagnosis in
primary care is challenging as the majority of
patients who present to their general practi-
tioner (GP) with respiratory symptoms will
not have lung cancer.5 Survival rates in the
UK from lung cancer are poorer than in
other European countries6 and it may be
that negative beliefs about barriers to symp-
tomatic presentation contribute to this.7
Understanding how patients recognise pos-
sible signs of lung cancer and the decisions
they make about seeking help for their
symptoms can inform the development of
interventions to reduce the time to diagnose
lung cancer and potentially improve
survival.
KEY MESSAGES
▸ We believe this study is the first to compare the
appraisal and help-seeking experiences of
patients with symptoms indicative of lung
cancer (such as cough, dyspnoea, haemoptysis,
chest and back pain) between people subse-
quently diagnosed with lung cancer and people
diagnosed with other non-cancer conditions.
▸ The study was guided by the Aarhus statement
recommendations on improving design and
reporting of studies on early cancer diagnosis.
▸ Recruiting at the time of referral to specialist
respiratory services and interviewing patients
before or close to diagnosis reduced risk of post
hoc rationalisation and recall bias.
▸ Almost half of the study group visited the
general practitioner (GP) two or more times
before an appropriate investigation or referral
was made, enabling us to report on the patient
perception of GP advice on symptom monitoring
and on when to reconsult.
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The timeliness of patient help-seeking for potential
cancer symptoms is inﬂuenced by a number of factors.
A UK population survey, using the validated Cancer
Awareness Measure, identiﬁed four key barriers to
timely help-seeking: perceived service barriers, that is, dif-
ﬁculty getting an appointment; practical barriers, that is,
lacking the time or transport to attend the consult-
ation; emotional barriers that is, fear of receiving bad
news, and failing to interpret the symptom/s as requiring
medical attention.8 Studies explicitly investigating the
help-seeking experiences of people diagnosed with
lung cancer have reported similar barriers.9–15
Furthermore, the recognition of new respiratory symp-
toms is particularly difﬁcult for patients who have a
lung comorbidity such as chronic obstructive pulmon-
ary disease (COPD).5 Many patients at risk of lung
cancer have a history of smoking, which can further
prolong help-seeking owing to perceived risks of being
stigmatised and of not being worthy of medical help.10
Raising awareness of cancer symptoms may help to
promote timely help-seeking. Public health campaigns
such as the ‘Be Clear on Cancer’ lung cancer campaign16
have been used to raise awareness of the signs of lung
cancer. At a community level, there is evidence of
increased awareness of lung cancer symptoms and
increase in referrals to specialist respiratory services
during similar campaigns.17 18 However, understanding
the possible cause of a symptom does not always directly
translate into seeking a consultation to discuss such symp-
toms.19 People have to make complex decisions about
when it is appropriate to seek help, and in part these
decisions are inﬂuenced by perception of personal risk.20
Decisions to seek help are also shaped by public and pro-
fessional perception of what is a reasonable time to wait
for symptoms to resolve spontaneously. While there is
general consensus that ‘red ﬂag symptoms’ such as haem-
optysis21 should be presented and referred urgently,
National Institute for Clinical Evidence (NICE) recom-
mends that other respiratory symptoms such as cough
and dyspnoea should have been present for at least
3 weeks before investigation by chest X-ray.22 Therefore,
it is important that we more fully understand the reason-
ing behind patients’ help-seeking decisions for a range of
respiratory symptoms in order that interventions, particu-
larly those aimed at promoting presentation of symptoms,
can be developed to improve timeliness of help-seeking.
To date, studies exploring patient appraisal and help-
seeking for symptoms suggestive of lung cancer have only
reported the experiences of those diagnosed with lung
cancer, and have interviewed or surveyed patients often
several months or years after diagnosis. These studies
may be biased by post hoc rationalisation and recall bias.
Patients are more likely to recall their appraisal and help-
seeking decisions fully if they are interviewed as close as
possible to the time they were experienced, and prefer-
ably before their diagnosis is known.
Our aim was to understand the symptom evaluation,
or ‘appraisal’, and help-seeking decisions of patients
with symptoms suggestive of lung cancer. In this paper,
we report the results from an interview study that
recruited people with respiratory symptoms referred to
specialist respiratory services for consideration of pos-
sible cancer, irrespective of their subsequent diagnosis.
This method enabled us to explore the complex pro-
cesses and events that shaped patient appraisal and help-
seeking from when they ﬁrst noticed a symptom, to ﬁrst
consultation with a healthcare professional (HCP),
through until they were referred.
METHODS
Design and definitions
This in-depth, face-to-face interview study was nested
within the SYMPTOM Lung Study (http://discovery-
programme.org/symptom_study.php). The SYMPTOM
study was a prospective cohort study investigating associa-
tions between symptoms and other factors on the total
diagnostic interval and stage of diagnosis among patients
with symptoms suggestive of lung, colorectal and pancre-
atic cancer. This interview study used qualitative methods
to explore the factors that affected patient appraisal and
help-seeking for respiratory symptoms. Ethical approval
was obtained from Cambridgeshire 3 Research Ethics
Committee (10/H0306/50).
The study design, including data collection and ana-
lysis, was underpinned by the theoretical approach of
the Model of Pathways to Treatment (ﬁgure 1).23 24 The
model enables explicit consideration of patient, disease
and healthcare factors that impact on patients’ appraisal
of symptoms and decisions to seek help. Using a theoret-
ical framework and the deﬁnitions of events along the
patient pathway reﬂects best practice as deﬁned in the
Aarhus Statement.25 Detecting bodily change, perceiving
a reason to seek help and ﬁrst consulting a HCP are key
‘milestones’ or events in the pathway to treatment, and
represent the ‘time to presentation’ (TTP).25 We deﬁne
TTP as the interval between the patient-reported date of
ﬁrst noticing a symptom and their ﬁrst consultation with
an HCP, usually their GP. However, as one-third of
patients with lung cancer consult their GP three times
before referral,26 for participants who are not referred
after the ﬁrst consultation, we have also deﬁned their
further symptom appraisal and decisions to seek help
again as the ‘Re-appraisal Interval’. This deﬁnition has
resonance with the iterative nature of the Appraisal and
Help-seeking Intervals as illustrated in the Pathways to
Treatment model, ﬁgure 1.
Study setting and recruitment
Recruitment to the study was undertaken when patients
were referred to specialist respiratory clinics in second-
ary and tertiary care at ﬁve hospitals in the East and
North East of England. Patients aged 40 years and over,
referred to hospital via urgent (2 week wait), routine
and diagnostic routes, for whom GPs had reported
symptoms potentially suggestive of lung cancer, were
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mailed an introduction letter and SYMPTOM question-
naire, and invited to join the SYMPTOM study. They
were also invited to take part in this interview study. We
purposively sampled participants by region, selecting for
variation of age, gender, educational level and diagnoses
(cancer/other non-cancer).
Data collection
Interviews were undertaken by NH, KM and LB between
November 2011 and January 2013. Interviews were con-
ducted as soon as possible after referral to specialist
respiratory care, the majority within 10 weeks. Twelve
participants were unaware of their diagnosis at interview
(2 lung cancer). All diagnoses were conﬁrmed from
review of secondary care medical records.
Interviews were preceded by an explanation of the
research process and signing of a consent form; consent
was also rechecked at the end of each interview. We then
used open-ended questions to explore the participant’s
appraisal of symptoms and help-seeking decisions with
questions developed from our experiences of undertak-
ing similar interviews with people recently diagnosed
with cancer.20 Concepts explored included description
and appraisal of the initial symptom/s and any self-care;
the appraisal of subsequent symptom/s and the trigger/s
that prompted consultation with an HCP; and the
outcome of this consultation, and any further appraisal
and help-seeking decisions. We probed the participant’s
understanding of symptoms, previous knowledge and
understanding of lung cancer, and social inﬂuences on
their decisions. A speciﬁcally developed calendar land-
marking instrument was used to assist with participant
recall, which helped to clarify the sequence and dates of
events and intervals during their pathway to diagnosis.27
Interviews lasted between 40 and 65 minutes and were
usually conducted in the participant’s home; one person
chose to be interviewed in university ofﬁces and another
in their workplace. In several of the interviews a relative,
usually spouse, was present. Relatives contributed to the
interview by conﬁrming participant’s comments or adding
detail to the account. Interviews continued until saturation
of data, when no new themes were identiﬁed in three con-
secutive interviews.28 Audio-recordings of interviews were
professionally transcribed verbatim and anonymised.
Analysis
Analysis was an iterative process that started after the
ﬁrst few interviews. Framework analysis methods were
used to ensure a systematic and rigorous progression
through the ﬁve analytic steps: familiarisation with data;
developing thematic framework; indexing data to frame-
work; mapping and questioning the data; and theoret-
ical interpretation.29 The thematic framework was
developed by NH and KM in consultation with FW and
LB; our study patient representative (MJ) also contribu-
ted to all stages of analysis. Data management was
assisted by NVivo V.9.
During the mapping and questioning of data, we
examined transcripts of participants diagnosed with
lung cancer and compared them with those who pre-
sented with similar symptoms but who were diagnosed
with other non-cancer conditions. We explicitly consid-
ered symptom appraisal, decisions about help-seeking,
re-appraisal and further help-seeking. Following thematic
Figure 1 Model of pathways to treatment (HCP, healthcare professional).
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analysis, data were charted by patient characteristics (age,
gender, smoking, lung comorbidity and geographical
region) to seek patterns or non-conﬁrming cases between
those diagnosed with lung cancer and those diagnosed
with other non-cancer conditions.
RESULTS
Patient characteristics
Seven hundred and seventy-six (81% n=963) of the par-
ticipants recruited into the main SYMPTOM Lung study
expressed an interest in taking part in the interview
study. We undertook purposive sampling among this
group, and only seven people declined to be interviewed
because they were feeling unwell or were too busy with
hospital appointments.
We undertook 35 interviews; 17 participants were diag-
nosed with lung cancer and 18 with other conditions.
Table 1 shows the sociodemographic characteristics of
the cohort, as reported in the SYMPTOM Lung study.
The characteristics of the interview study cohort were
similar to those of the SYMPTOM Lung study, although
there were more smokers in the interview study. We pur-
posefully sampled for people with a cancer diagnosis. In
the interview study nearly half (49%) of the cohort had
lung cancer compared with only 16% in the questionnaire
study. Both cohorts had similar sociodemographic
characteristics (ethnicity, education, employment). In the
interview study nine reported they had existing lung
comorbidity (4 COPD, 3 asthma, 2 other lung conditions).
Of the 17 participants diagnosed with lung cancer,
one had a lung metastasis from a primary colon cancer;
eight had disease staged with potential for treatment
with curative intent (stage I n=4; stage II n=4), while
eight had more advanced disease (stage III n=1; stage IV
n=7). The 18 participants with other conditions mainly
had inﬂammatory conditions, see table 1.
Duration of respiratory symptom/s
Seven participants did not seek help because of respira-
tory symptom/s; however, they did retrospectively recall
respiratory symptoms and these data were included in
our analysis. Three were referred to respiratory clinics
following CT scan or MRI for non-respiratory symptoms,
which reported lung abnormalities (2 lung cancer), and
four had their respiratory condition opportunistically
detected during consultations with GPs for other health
concerns (2 lung cancer).
Most of the remaining 28 participants could recall
when they ﬁrst noticed their symptom/s and the date
they went to the GP, though many were unable to recall
the exact date they decided to seek help (ie, the start of
the Help-seeking Interval in ﬁgure 1). We report the
Appraisal Interval and ﬁrst Help-seeking Interval as the
TTP. The TTP ranged from 2 to 334 days; just under
half consulted within 30 days of ﬁrst noticing a
symptom. Table 2 presents the characteristics of partici-
pants in the quartiles with the shortest and longest TTP,
demonstrating similarities in age, gender, initial
symptom attributions and trigger for help-seeking
between those diagnosed with lung cancer and those
diagnosed with other non-cancer conditions.
For the 16 (6 lung cancer) who consulted their GP
two or more times before referral to specialist respiratory
services, we also report the number of days between their
ﬁrst consultation and their referral: the Re-appraisal
Interval. The time between ﬁrst consultation and referral
was between 10 and 182 days; for seven participants it was
over 60 days (2 lung cancer). There were similarities in
the Re-appraisal Interval between participants diagnosed
with lung cancer and those diagnosed with other non-
cancer conditions, although overall, patients diag-
nosed with lung cancer had fewer GP visits and were
mainly referred under the 2 week wait referral system
(table 3).
Qualitative themes
We found many similarities in the appraisal and help-
seeking of participants who were diagnosed with lung
cancer compared to those diagnosed with other condi-
tions. Only two participants reported that they immedi-
ately thought of cancer because of their symptoms
(1 lung cancer). We report the data in three sections:
▸ The appraisal of symptoms describes how they are difﬁ-
cult to recognise, and that lung comorbidities often
masked respiratory changes, the alternative explana-
tions offered for the cause of symptoms, and the ways
in which symptoms were self-managed prior to
help-seeking.
▸ Deciding to seek help describes the factors that helped
to endorse a decision to seek a GP consultation,
including symptoms such as signs of acute illness,
recognising a changing symptom, symptoms not
responding as expected, the inﬂuence of family
members and the social network, increased awareness
of lung cancer and the impact of smoking on
help-seeking.
▸ Symptom re-appraisal and returning to the GP describes
the factors that shaped the decision to seek a further
consultation including symptom change, increasing
impact of symptom on activities, increasing concern
about personal risk of having lung cancer and the
role of the GP in endorsing such help-seeking.
Extracts from interviews illustrate the results; each
quotation is contextualised by the participant’s gender,
age band, smoking history, TTP in days, diagnosis
(cancer, non-cancer) and if diagnosis was not known at
time of interview.
The appraisal of symptoms
The ﬁrst interval in the patient pathway is the appraisal
and self-management of symptom/s. If a symptom was
difﬁcult to recognise, attributed to ageing or smoking,
or appraised as a condition that could be self-managed,
participants often remained for some time in the
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appraisal interval. We found no evidence of differences
between those diagnosed with lung cancer and those
diagnosed with other non-cancer conditions across any
of the factors, as shown in table 4.
Difficult to recognise
The insidious nature of some respiratory symptoms made
it difﬁcult to recognise a change in respiratory function
“breathlessness has been creeping up” (M, 55–59,
Table 1 Participant characteristics
Diagnosis
Lung cancer
N=17
Other conditions*
N=18
Interview study
N=35
SYMPTOM Lung study
N=963
Location (England)
East 8 8 16
North East 9 10 19
Sex
Female 6 9 15 (42.9%) 441 (45.8%)
Male 11 9 20 (57.1%) 522 (54.2%)
Age mean years (range) 69 (57–83) 61 (41–88) 65 (41–88) 66 (40–95)
Ethnicity
White 17 16 33 (94.3%) 931 (96.7%)
Other – 2 2 (5.7%) 32 (3.3%)
Smoking
Current smoker 5 4 9 (25.7%) 115 (12.2%)
Ex-smoker 10 6 16 (45.7%) 517 (54.8%)
Never smoked 2 8 10 (28.6%) 311 (33.0%)
Education
Up to higher education 10 13 23 (65.7%) 655 (68.0%)
Higher education or equivalent 7 5 12 (34.3%) 308 (32.0%)
Employment†
In employment 2 6 8 (23.5%) 274 (30.4%)
Disabled or unemployed 2 4 6 (17.6%) 56 (6.2%)
Retired 12 8 20 (58.8%) 570 (63.3%)
IMD quintile‡
Least deprived 1 5 6 11 (31.4%) 317 (32.9%)
2 4 3 7 (20%) 216 (22.4%)
3 2 3 5 (14.3%) 160 (16.6%)
4 2 4 6 (17.1%) 126 (13.1%)
Most deprived 5 4 2 6 (17.1%) 143 (14.9%)
Number of GP appointments§
1 9 7 16
2 or more 6 10 16
Type of referral to specialist services¶
Urgent (2WW) 14 8 22
Routine 0 8 8
Comorbidities
Respiratory
COPD 1 3 4
Other lung conditions 1 4 5
Other
Previous cancer** 2 1 3
Diabetes 3 1 4
Heart disease 4 4 8
Arthritis 3 7 10
Anxiety/depression 3 2 5
IBS 2 2 4
*Other conditions: pneumonia (3), COPD (2), asthma (1), pleurisy (1), fibrosis asbestosis (1), eosinophilic bronchitis (1), allergic rhinitis (1),
acid reflux (1), calcified lung lesion (1), weight gain (1), post-infection sensitivity (1), nil abnormal found (3) and unreported (1).
†Missing data interview study n=1: questionnaire study n=63.
‡The IMD is a key data set on deprivation. The Indices measure levels of deprivation across seven distinct domains: Income Deprivation,
Employment Deprivation, Health Deprivation and Disability, Education Skills and Training Deprivation, Barriers to Housing and Services,
Living Environment Deprivation and Crime.
§Three participants referred following MRI or CT for other conditions.
¶5 Missing: missing data=3; referred through secondary care hospitals to tertiary centres=2.
**Previous cancer sites: kidney (1) and bowel (2).
COPD, chronic obstructive pulmonary disease; GP, general practitioner; IBS, irritable bowel syndrome; IMD, Index of Multiple Deprivation.
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Table 2 Comparison of attribution and symptom/s that triggered help-seeking between participants with the shortest and longest quartile in the interval from first noticing a
symptom to first presentation (ordered by first TTP)
TTP
(days) Sex Age
Smoking
status Comorbidity Dyspnoea Haemoptysis
Dry
cough
Productive
cough
Chest
pain
Back
pain
Tightness
in chest
Increased
tiredness
Initial patient
attribution
Lung
cancer
Time between noticing a system and seeking help—shortest quartile
2 F 45–49 Never Asthma, IBS ● ○ Sinus infection
7 M 65–69 Never Arthritis ● Gallstones
7 F 80–84 Ex – ● Flu
7 F 65–69 Ex – ○ ● ● Chest infection ✓
14 F 50–54 Ex Anxiety
depression
● Chest infection
14 M 70–74 Ex – ● Getting older ✓
15 F 55–59 Current – ● ● Chest infection
21 M 65–69 Ex – ● Muscle pain ✓
Time between noticing a symptom and seeking help—longest quartile
49 M 80–84 Current – ● ○ Getting older ✓
49 M 60–64 Ex – ● Muscle pain ✓
60 F 55–59 Never – ● Allergy
58 M 60–64 Ex – ● Over exertion ✓
60 M 55–59 Current – ● ○ Cardiac
problems
120 F 40–44 Never – ○ ● ○ ○ Chest infection
150 M 65–69 Ex Heart disease ● ○ Cancer ✓
180 M 80–04 Ex Heart disease,
diabetes
● Asbestos in lung
● Indicates symptom/s that triggered help-seeking. ○ Indicates symptom/s reported that did not trigger help-seeking.
F, female; M, male; IBS, irritable bowel syndrome; TTP, time to presentation.
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smoker, 60 days, non-cancer). An elderly man diagnosed
with lung cancer explained he felt “not quite right,
yucky, bit weary and tired”. He said he could not
describe his symptoms sufﬁciently to justify visiting the
doctor and waited 8 weeks before consulting his GP.
Having a lung comorbidity, such as COPD, could
make it difﬁcult to notice a change in symptom/s and
some participants were only alerted to their respiratory
symptom during consultations for other conditions:
I’ve always been breathless for 30-odd, it’s 34 years since
I got this heart disease, then I have COPD and emphysema.
(M, 55–59, smoker, opportunistically detected, cancer)
Seven participants had not sought help for their symp-
toms although, in retrospect, those diagnosed following a
CT scan or MRI for another reason, could often recall
respiratory symptoms. These symptoms had not caused
them concern as this woman diagnosed with lung cancer
said about her cough:
P. I suppose it’s been going on a while
Int. Would that be a few weeks or less than that?
P. Oh, more than that it was a dry tickly cough
Int. Ok, have you had any breathlessness?
P. A little, but that could be for other reasons…had it not
been picked up on the scan I still wouldn’t have gone to
the GP. (F, 65–69, never smoked, opportunistically
detected, cancer, diagnosis not known)
Alternative explanations for respiratory symptoms
Alternative explanations provided for the cause of symp-
toms were usually contextualised by anticipated changes
in bodily function, or as a reaction to speciﬁc activities.
For example, older people may expect to be more breath-
less on exertion: “I noticed maybe a few time I was not
able to walk as fast as I used to be able to do, but I didn’t
think much about it…I am 72 I am going to begin to slow
down” (M, 70–74, ex-smoker, 14 days, cancer).
Not all smokers mentioned smoking when discussing
their appraisal or help-seeking but the few who did
explained their symptom could be due to smoking.
Another explanation, particularly for pain, was muscle
strain. The explanation was justiﬁed within the context of
activity: “I do a lot of work around the garden, picking
things up, obviously muscles go into a bit of a spasm, so
not to worry” (M, 65–69, ex-smoker, 21 days, cancer).
Self-management of symptoms
During the appraisal interval some participants tried to
contain and self-manage their symptoms. By drawing on
their knowledge about the cause of similar symptoms,
their judgements about the cause of their symptom
inﬂuenced subsequent decisions to seek healthcare:
It started in February and I just thought a tickly cough, it
just went on and on and I thought it was a cold and then
Table 3 Re-appraisal Interval: time between first noticing a symptom to first consultation and first consultation until referral
to specialist respiratory services, by time intervals (ordered by first TTP)
Time from noticing
a symptom to first
consultation
(TTP) (days)
Time from first
consultation
to referral
(Re-appraisal)
(days)
Number of
consultations
Type of
referral
Gender
and age
Diagnosis or lung
cancer staging (T N M)*
Diagnosed with cancer
1 3 60 2 Urgent M, 75–79 IB 0 0
2 7 14 2 Urgent M, 75–79 IV 2 IA
3 21 14 2 Urgent M, 65–69 IV 2 IA
4 49 35 2 Urgent M, 80–84 IIA I 0
5 50 102 4 Urgent F, 70–74 IV 3 IA
6 90 133 4 Urgent F, 55–59 IIB 0 0
Diagnosed with other conditions
7 2 28 3 Routine F, 45–49 Nil abnormal detected
8 2 35 4 Routine F, 50–54 Emphysema
9 7 182 3 NA F, 80–84 Interstitial pneumonia
10 14 80 3 Routine F, 50–54 Asthma
11 15 63 2 Urgent F, 55–59 Emphysema
12 30 138 4 Urgent F, 65–69 Eosinophilic bronchitis
13 60 10 2 Urgent M, 55–59 Tracheobronchitis and GORD
14 60 34 3 NA F, 55–59 Seasonal allegoric rhinitis
15 60 60 2 Routine M, 55–59 COPD
16 120 126 4 Routine F, 40–44 Erythema suggestive of GORD
*T=tumour size; N=Regional lymph; M=Distant metastasis; Stage of cancer is indicative of whether treatment will be curative in intent.
COPD, chronic obstructive pulmonary disease; F, female; GORD, Gastro-oesophageal reflux disease; M, male; NA, not applicable; TTP, time
to presentation.
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I thought, perhaps it’s the beginning of hay fever so I just
kept leaving it, trying hay fever tablets. (F, 40–44, never
smoked, 121 days, non-cancer)
An alternative explanation for self-managing the symptom
was occasionally situated within a dislike of attending the
doctor’s surgery:
I don’t particularly enjoy going to the doctors so I went
to the chemist and gradually built up a line of medica-
tion from the chemist these cough bottle I decided I
would take rather than going to the doctors. (F, 65–69,
never smoked, 30 days, non-cancer, diagnosis not known)
Deciding to seek help
The decision to consult an HCP and move from apprais-
ing symptoms to seeking help was triggered by patient,
disease and, to lesser extent, healthcare factors.
Appraising symptom/s as a sign of acute illness
prompted timely help-seeking. Family members and
friends recognised symptoms in the participants and
encouraged them to seek help. Increasing awareness of
the signs of lung cancer, usually due to the ‘Be Clear on
Cancer Campaign’, prompted help-seeking. Participants
did not report that their smoking behaviour was an
inhibitor to help-seeking. Competing responsibilities
and limited access to healthcare prolonged the TTP for
only a few participants, see table 4.
Symptoms as a sign of acute illness
Just over half of the participants consulted their GP
within 30 days of ﬁrst noticing their symptom, usually
when it was attributed to a chest infection, see table 4.
Drawing on previous experience and knowledge they
quickly sought a consultation anticipating a prescription
to alleviate symptoms:
I thought it might be chest infection in which case you
know, antibiotics and away you go. (F, 65–69, ex-smoker,
7 days, cancer)
I thought that I needed maybe some antibiotics if I’d got
a chest infection. (F, 50–54, smoker, 2 days, non-cancer)
When acute illness was experienced help-seeking was
rapid, and those diagnosed with cancer and those
Table 4 Time to Presentation (TTP): factors that impacted on symptom appraisal and initial help-seeking across people
diagnosed with lung cancer and those diagnosed with other conditions
Participants diagnosed with lung cancer Participants diagnosed with other conditions
Factors that increased timeliness of help-seeking
Symptom sign of
acute illness
You do the usual, you take your Lemsip’s and
your Beechams Powders and when it doesn’t
clear up after a week you think well you need
some antibiotics or something slightly stronger.
So that was when I went to the doctors
(M, 75–79, smoking not recorded, 7 days)
I went to the doctor actually quite quickly because
I had to fly and I knew that I would have trouble
in the aeroplane if I didn’t get some medication
(F, 50–54, ex-smoker, 14 days)
Symptom caused
concern
I went up a slight slope, and when I got to the top
I was absolutely panting and really short of
breath. … And I sat till I got my breath back, then
I carried on normally, but when I got back home,
on thinking about it, it wasn’t right, and so that
was the trigger point (M, 70–74, ex-smoker,
15 days)
I found myself very short of breath the onset was
very quick and I thought ‘I don’t think I should feel
like this’, and I thought if I’m puffing like this rang
the surgery and said ‘do you think you could make
me an appointment for the next day because I’m
really short of breath (F, 80–84, ex-smoker, 7 days,
diagnosis not known)
Influence of
family
Wife persuaded me to go to the doctor about it.
I wasn’t too worried about it, it wasn’t significant
to me (M, 75–79, ex-smoker, 10 days, diagnosis
not known)
It didn’t get any better, it got worse. So (daughter’s
name) would say, mother, that cough is awful and
husband was saying the same (F, 65–69, never
smoked, 30 days, diagnosis not known)
Factors that prolonged TTP
Competing
responsibilities
I was so damn busy, too busy to think of this…I
was busy with all sorts of things, work and
everything, and eventually I made the
appointment (F, 70–74, ex-smoker, 50 days)
It started about the end of October in Australia and
I saw my doctor about, the Monday before
Christmas, … the cough had got worst whilst I was
away (F, 55–59, never smoked, 60 days)
Misattribution of
symptoms
I thought it was my asthma getting worse
because I was getting more breathless I honestly
truly believed it was my asthma getting worse
(F, 55–59, ex-smoker, 90 days)
Breathlessness 2 or 3 months, but I mean it’s just
something which is coming on, so you don’t get
over concerned (M, 55–59, smoker, 60 days,
diagnosis not known)
Healthcare
factors
I didn’t go because I couldn’t explain it. I thought
I don’t want to waste his time just saying “I’ve,
somehow I feel a bit strange” or whatever it is
(M, 75–79, ex-smoker, 56 days)
Whenever I’m out of this situation (immigrant visa
expired) then I will go and you know talk to the GP
about it (M, 40–44, never smoked, 334 days,
diagnosis not known)
F, female; M, male; TTP, time to presentation.
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diagnosed with other non-cancer conditions both said
they had been well before their acute symptoms. When
asked to clarify how long she had been feeling breathless
one woman explained “maximum a week, up until then
was still swimming 3 times a week, I’d walk for a good
hour every day, I’d play table tennis just carry on as
normal” (F, 65–69, ex-smoker, 7 days, cancer).
Symptoms not appraised as being due to a lung condi-
tion were often also attributed to an acute illness based
on previous experience. For example, one man with a
history of intermittent pain in the lower back and recent
gallstones attributed his pain to a kidney infection and
sought help promptly.
Recognising a changing symptom
Having a lung comorbidity meant patients were already
living with chronic respiratory symptoms yet they were
still able to disentangle and identify the ‘unusual’ or
changing symptom. Even when a symptom was distinct
from what was normally experienced some undertook
‘watchful waiting’ to see if the change was repeated
before seeking help:
I’ve got COPD but I never coughed up blood before. I
thought it will clear up but after two weeks it didn’t so I
thought I had better get it checked. (M 70–74,
ex-smoker, 14 days, non-cancer)
When other factors highlighted the change, such as
the failure of self-management or usual treatment to
control the symptom, then the need for timely help-
seeking was reinforced:
It wasn’t like my normal asthma cough, I’d use my
inhaler it had no impact at all … still continue coughing.
(F, 45–49, never smoked, 2 days, non-cancer)
Symptoms not responding as expected
When symptoms were appraised as being self-limiting
and not requiring medical intervention, such as due to
allergy or muscle strain, help-seeking was only instigated
when the symptom continued or failed to respond in
the expected way. A cough appraised as an allergy that
did not improve when the seasons changed triggered an
initial consultation.
A seasonal allergy… (then it’s) December, it’s freezing
cold and I was continuing to cough so I rang the doctor.
(F, 55–59, never smoked, 60 days, non-cancer)
Similarly, with an appraisal of muscle pain there was
the expectation that the pain would subside. When this
did not happen or the pain increased there was an
urgency to seek help:
It (back pain) got worse and worse, absolute agony…we
had a couple of nights on holiday and I thought if it is
still aching when I get back I’ll call the doctor…we actu-
ally got back at 3 in the morning and I actually managed
to get an appointment that day. (M, 65–69, ex-smoker,
21 days, cancer)
Influence of family members and the social network
A persistent cough was reported by approximately a
third of participants (7 lung cancer). The cough was
usually publicly noticeable, for instance, the tickly cough
which made it difﬁcult to talk and led to retching, and
the expectorant cough with sputum and tissues. Family
members, friends and work colleagues readily commen-
ted on a persistent cough:
Our friends were saying “Oh you know that cough is
dreadful… it’s just going on and on.” (F, 55–59, never
smoked, 60 days, non-cancer)
A friend said perhaps you ought to get that cough looked
at. (F, 70–74, ex-smoker, 50 days, cancer)
Older participants tended to attribute increasing
breathless to a normal part of aging and their help-
seeking was also often prompted by relatives, illustrating
the importance of raising awareness of cancer symptoms
in the older population:
My daughter said “I’ve never walked with you and you’ve
lagged behind…” then she started to question about this
breathing. (M, 80–84, smoker, 49 days, cancer, diagnosis
not known)
When symptoms were ignored by the participant, the
family was proactive in endorsing and sometimes orga-
nising the ﬁrst consultation:
Probably I’ve been ignoring it for a few weeks, you
know… the wife took it out of my hands she phoned the
doctor. (M, 55–59, smoker, 60 days, non-cancer, diagnosis
not known)
Even when participants lived alone, those who spoke
to family and friends about their symptoms were encour-
aged to consult a GP, “brother said ‘I’m telling you now
to go to the doctor” (M, 70–74, ex-smoker, 14 days,
non-cancer).
Another man who lived alone explained “my friend
went up to see the doctor and said I was in a bad way
and the GP came here” (M, 60–64, ex-smoker, internal
hospital referral for sleep apnoea tests, non-cancer).
Increased awareness of lung cancer
A cough was often the symptom that triggered help-
seeking. Public awareness of a cough as a sign of lung
cancer was raised by the ‘Be Clear on Cancer’ Lung
cancer campaign, which ran across England during the
period of interviewing.16 Five participants had seen the
information and they focused on the headline message
about cough being a warning sign of cancer but could
not recall the other symptoms. Two did not have a
cough so did not feel the advert applied to them. One
said it had raised their awareness of their cough and
Birt L, Hall N, Emery J, et al. BMJ Open Resp Res 2014;1:e000067. doi:10.1136/bmjresp-2014-000067 9
Open Access
group.bmj.com on August 7, 2015 - Published by http://bmjopenrespres.bmj.com/Downloaded from 
triggered their help-seeking, although it had not specif-
ically heightened their concern of lung cancer:
Until that advert came on, I never really took much
notice of this cough… then it dawned on me I had this
cough for a couple of weeks, so I waited till the third
week and I went. (F, 55–59, smoker, 15 days, non-cancer,
diagnosis not known)
The remaining two reported that the information had
little impact, as they had already made the decision to
book a GP consultation. Furthermore, one reported the
campaign had slightly prolonged their help-seeking:
Had that not been screened I would have been to the
doctors the week before, because I was saying to myself,
it’s just ‘cos that’s on you’re getting worried, so it had the
adverse effect. (M, 65–69, ex-smoker, 150 days, cancer)
Impact of smoking on help-seeking
Those who had a history of smoking did not initially
seek medical help with a concern of possible lung
cancer and being a smoker did not impact on TTP, as in
table 2. Rather, the cancer risk implicit in smoking was
considered more when participants reappraised their
symptoms following the ﬁrst consultation. Nonetheless,
when there was a change in the smoker’s cough the
decision was made to seek help:
Because if you are a smoker, see ﬁrst thing in the
morning it gets you, well I was waking up through the
night with this dry cough, but it never lasted long and
that’s when I really started ooh have I got cancer, like
lung cancer. (M 55–59, smoker, 60 days, non-cancer, diag-
nosis not known)
Symptom re-appraisal and returning to the GP
Participants were generally happy with the outcome of
their initial consultation, but when the prescribed treat-
ment was not effective or their symptom changed, they
started a process of re-appraisal and made decisions
about whether to seek another GP consultation. There
were similarities in the help-seeking decisions of those
diagnosed with lung cancer and those diagnosed with
other non-cancer conditions (see table 5).
In this section each quotation is contextualised by the
participant’s gender, age band, smoking history, TTP in
days, re-appraisal time in days and diagnosis.
Symptom change triggering further help-seeking
Following their initial consultation, an awareness of
symptom changes often triggered a further GP consult-
ation. For some it was the recognition of new symptoms:
We all sort of joked about my cough, but no, I was ser-
iously very, very tired, and I suddenly thought “My God, I
feel I’ve aged ﬁve years in ﬁve months…” and I thought
no, wait a minute, you are breathless as well. (F, 70–74,
ex-smoker, TTP 50 days, Re-appraisal 102 days, cancer)
For others it was the persistence or an increase in the
severity of one or more of their symptoms that made them
decide to seek further help:
The coughing was worse and it started really hurting my
lungs and I started really being nervous about it because
every time when I coughed it felt like as if I was ripping
my lungs apart, it was really painful. (F, 50–54, ex-smoker,
TTP 14 days, Re-appraisal 80 days, non-cancer, diagnosis
not known)
When the symptom was recognised as a warning sign,
such as coughing up blood, the urgency to return to the
GP increased for some but not all people (table 5). For
example, if the blood in the sputum could be attributed
to other causes, the urgency to seek further help was
reduced, as illustrated by a man who was using inhalers
following his ﬁrst consultation:
I started to cough I noticed ﬂecks of blood. I took no
notice of it and thought possible it was the stuff I was
breathing in, or that it is just a burst blood vessel in my
lungs. (M, 80–84, smoker TTP 49 days, Re-appraisal
35 days, cancer)
Increasing impact of symptom on activities
During the re-appraisal, participants described how
symptom/s increasingly curtailed their ability to under-
take work and leisure activities. This increasing impact
of symptoms on activities acted as a trigger to reconsult:
I was trying to go to the shop and it was getting to be a
bit of an embarrassment because in the shop, if I
coughed me eyes would water and I’d choke or be sick.
So I’d have to leave me shopping, come out the exit, try
to pull myself together, then go back in. (F, 65–69, never
smoked, TTP 30 days, Re-appraisal 138 days, non-cancer,
diagnosis not known)
Increasing concern at personal risk of lung cancer
During the process of re-appraisal of symptoms several
participants became increasingly concerned their symp-
toms were indicative of lung cancer. Personal predispos-
ition for lung cancer was considered within the context
of family history and previous environmental exposure
to carcinogenic materials, particularly smoking. Drawing
on their knowledge of lung cancer from seeing relatives
or friends with the disease, the match or mismatch in
symptoms shaped their re-appraisal and subsequent
decision to seek further help:
My dad was coughing sputum, he coughed a lot of
sputum, but I haven’t, so they were totally different. My
dad had a cough, I didn’t have a cough, so there was a
lot of differences… so the furthest thing from my mind it
was going to be lung cancer. (F, 55–59, ex-smoker, TTP
90 days, Re-appraisal 133 days, cancer)
I thought it was lung cancer ‘cos my mam died of lung
cancer… she used to always have like a dry cough, and I
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was having a bit of a dry cough. (M, 55–59, smoker, TTP
60 days, Re-appraisal 60 days, non-cancer, diagnosis not
known)
Heightened concern about personal risk for lung
cancer due not only to smoking but also to environmen-
tal exposure seemed to facilitate further help-seeking:
I’ve been smoking all my life more or less, I did work
with asbestos when I was an apprentice and you think
well maybe this is what it is all about maybe you have got
cancer. (M, 55–59, smoker, TTP 60 days, Re-appraisal
10 days, non-cancer, diagnosis not known)
GPs role in endorsing further help-seeking
The decision to reconsult was not always an easy one.
A minority of participants reported they felt the GP was
dismissive of their symptom/s and concerns, “I said no,
no, you’re not listening to me I’ve had this cough for
ages and ages, it’s not just an overnight thing” (F, 65–69,
never smoked, TTP 30 days, Re-appraisal 138 days, non-
cancer, diagnosis not known).
Explicit advice on when to return seemed to legitimise
a further consultation even when new symptoms had not
developed (table 5). However, the absence of advice on
further monitoring of symptoms and the appropriate-
ness of a further consultation led some to revert to self-
managing symptom/s:
Doctor gave me some antibiotics and he said it would do
the trick. It didn’t… so I left it, I left it and I left it and I
continued another line of cough mixtures and stuff.
(F, 65–69, never smoked, TTP 30 days, Re-appraisal
138 days, non-cancer, diagnosis not known)
Management of comorbidities often led to regular
contact with their GP, but it was apparent that opportun-
ities to investigate symptoms suggestive of lung cancer
were not always maximised.
Table 5 Re-appraisal: factors that triggered further help-seeking following initial consultation across people diagnosed with
lung cancer and those diagnosed with other conditions
Participants diagnosed with lung cancer
Participants diagnosed with other
conditions
Concern about symptom I thought it strange to have a muscular problem
in my back that hadn’t got better in a couple of
weeks so I thought it might be something, not
necessarily sinister, well I suppose a slipped
disc or a bone problem (M, 65–69, ex-smoker,
21 days, 2 GP visits 14 days)
I coughed up a bright red blood clot. It was
while I was waiting to see doctor (for a
persistent cough), I phoned them up and
I said, “Look, I need to see someone and
I need to see someone today” (F, 55–59,
smoker, 15 days, 2 GP visits 63 days,
diagnosis not known)
Increasingly affected
ability to undertake
activity
I take the dog out every day and that was
getting less and less, the walk, so I knew
something was wrong and I was getting to the
stage where I didn’t want to take her (F, 55–59,
ex-smoker, 90 days, 4 GP visits 133 days)
Coughing with the fan heater and that kind of
dry heat and because of my job I go into hot
houses and then back to my car, back to hot
houses all the time and that set the coughing
off (F, 40–44, 120 days, 4 GP visits 126 days)
Increasing concern that
symptom indicative of
lung cancer
I read an article in the paper about a man who
had a cough for weeks, found he had lung
cancer and I remember thinking ‘oh god’ have
I got that (F, 70–74, ex-smoker, 50 days, 4 GP
visits 102 days)
My husband decided I’d got lung cancer.
(Laughs) Well a friend of ours had exactly
these symptoms and had lung cancer
F, 55–59, never smoked, 60 days, 3 GP visits
34 days)
Increasing concern about
candidacy for lung cancer
(Negative case) I was expecting a clean bill of
health, I mean I’ve never shown any sign of
illness, I’m 75 now and apart from the odd bit of
flu I’ve never really been ill all my life (M, 75–79,
smoking not recorded,7 days, 2 GP visits
14 days)
Because of the potential for methotrexate to
be a problem and the fact that I had had a
cough for longer than 3 weeks (F, 56, never
smoked, 60 days, 3 GP visits 34 days,
non-cancer)
I thought I am a smoker, I’ve been a smoker
for a lot of years that (cancer) crossed my
mind (F, 55–59, smoker, 15 days 2 GP visits
63 days, diagnosis not known)
Further help-seeking
endorsed by GP
The doctor said it looks like being muscular I’ll
give you some painkillers and come back in
couple of weeks if it hasn’t gone. So two weeks
exactly I went back (M, 65–69, ex-smoker,
21 days 2 GP visits 14 days)
The doctor asked me to go back in a fortnight
which I did (F, 81, ex-smoker, 7 days, 3 GP
visits 182 days, non-cancer, diagnosis not
known)
The doctor did say, try the steroids and the
one inhaler to start with, see how you go,
because you can come back (F, 40–45, never
smoked, 121 days, 3 GP visits 126 days)
F, female; GP, general practitioner; M, male.
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Because I had the x-ray in July Dr didn’t think it (pain)
would be anything but we would keep an eye on it. …I
was going to the doctors maybe once a fortnight, once a
month and every time it was for something else and I
forgot to mention it even though it was happening. (F,
55–59, ex-smoker, TTP 90 days, Re-appraisal 133 days,
cancer)
Consultations for comorbidities were not only with the
GP; symptoms suggestive of lung cancer were mentioned
to other HCPs but there was little evidence of effective
advice on symptom monitoring being provided to the
participants:
I go six monthly to the nurse in the clinic and I men-
tioned to her I was spitting blood and she said “well
make an appointment with the doctor” but I just went
out and never bothered. (M, 85–89, ex-smoker, 180 days,
non-cancer, diagnosis not known)
When this patient returned a few months later and
reported his haemoptysis again the nurse phoned the
doctor directly and he had a chest X-ray within 24 h.
DISCUSSION
Main findings
We believe this is the ﬁrst study to explore the appraisal
and help-seeking decisions of patients responding to
symptoms suggestive of lung cancer. Unsurprisingly,
there are few differences in the appraisal of symptoms,
decisions to seek help, TTPs and re-appraisal intervals
between people diagnosed with lung cancer and other
conditions. We found evidence of complex reasoning
and decision-making supporting the processes of decid-
ing whether and when to seek help. While patients
often recognised new symptoms or subtle symptom
changes, even against a background of the expected
symptoms of lung and cardiac comorbidities or being a
smoker, they often did not feel the need to seek help
because they developed alternative explanations based
on their previous experiences or believed they could
self-manage the symptoms. Help-seeking was triggered
by recognising the symptoms as signs of acute or serious
illness, the progression or persistence of existing symp-
toms or new symptoms, the inﬂuence of family members
and their social network, particularly due to the visibility
of symptoms, and sometimes current public health mes-
sages. Half the sample received treatment for other con-
ditions, such as for acute respiratory illness, and had not
been referred after their ﬁrst GP consultation. Symptom
monitoring and re-appraisal followed; returning to the
GP was again inﬂuenced by the progression or persist-
ence of existing symptoms or new symptoms, an impact
of symptoms on daily living activities, and increasing
concern about underlying serious disease and cancer.
We found little evidence that patients received adequate
advice from their GPs about symptom monitoring or
reasons to return for review.
Strengths and limitations
The major strength of this study is that we interviewed
people during their pathway to diagnosis and treatment,
often before they received their diagnosis; therefore we
were able to compare accounts of people diagnosed
with lung cancer and other non-cancer conditions. We
sought to interview people as early in their disease devel-
opment as possible. Interviewing 12 people before they
received their diagnosis helped to reduce post hoc
rationalisation and recall bias,9 11–13 and the remaining
interviews were conducted as soon as possible after diag-
nosis (range: 1 day to 16 weeks), with 15 (43%) occur-
ring within 4 weeks of diagnosis. Importantly, we were
able to include people with advanced stage cancer
before they became too ill to participate in research.
In accordance with the guidelines outlined in the
Aarhus Statement on improving design and reporting of
studies on early cancer diagnosis,25 we used a rigorous
study design with the theoretical Model of Pathways to
Treatment23 underpinning the interview schedule as
well as the analysis. The calendar-landmarking instru-
ment helped some participants recall dates and
symptom changes. Purposive sampling from two areas of
England ensured data were reported from people with
differing socioeconomic backgrounds and differing
exposures to carcinogenic environments. For example,
some people in the North East spoke of personal risk
due to proximity to, or employment in, heavy industry.
Our broad range of scientiﬁc and clinical expertise
helped ensure consensus in the ﬁndings, and we beneﬁt-
ted from the input of our lay member at all stages of the
research process, including interpretation of the data.
We acknowledge that the experiences of patients from
these two regions may not be representative of those
from other regions of the UK and that we cannot know
the experiences of those who did not take part,
although the interview sample has similar demographic
characteristics to the main SYMPTOM Lung study (see
table 1). Furthermore, we are only able to report the
perspectives of patients who had been referred through
primary care and had consulted their GP, but we have
not been able to access the appraisal or help-seeking
experiences of those who presented ﬁrst at accident and
emergency department.30
While we used a calendar-landmarking instrument
during the interviews to ensure, as far as possible, the
accuracy of time intervals, some people were unable to
recall precise dates and we took the dates from their
responses to the questionnaire in the main SYMPTOM
lung study. The nature of qualitative data collection is
such that we can only report the experiences patients
chose to divulge; it may be that they did not share experi-
ences that they considered to be private or embarrassing.
Comparison with existing literature
We recruited people with symptoms suggestive of lung
cancer, and included patients who were not aware of
their diagnosis at the time of interview, those who were
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diagnosed with other non-cancer conditions as well as
people diagnosed with early and later stage lung cancer.
We are therefore able to add new insights to the existing
literature on the experiences and decision-making pro-
cesses of people with lung cancer9–13 in order to
develop new targeted interventions to promote timelier
lung cancer diagnosis. We found that initial alternative
explanations for symptoms were based on patients’ previ-
ous experiences, for example, a dry cough during
summer was attributed to hay fever, and slight breath-
lessness in winter attributed to a chest infection. This is
concordant with ﬁndings from a UK interview study of
patients with operable and inoperable lung cancer,
which reported that they minimised, normalised or mis-
attributed symptoms.12 However, that study also reported
their patients lacked agency in seeking help; in contrast,
patients in our study tended to either adopt ‘watchful
waiting’ to see if symptoms improved, or to self-manage
symptoms with over the counter drugs.
Other studies interviewing people with lung cancer
have highlighted that lung and cardiac comorbidities,
such as COPD and asthma, can delay symptom appraisal
and timely help-seeking for lung cancer.9 12 We found
that many patients, especially those with comorbidities,
showed a complex and sophisticated ability to distin-
guish minor changes in respiratory function from pre-
existing symptoms due either to their comorbidities or
smoking habits. They quickly noticed either change in
their normal symptoms or the effectiveness of usual
medication. The recognition of changing effectiveness
of medication is a novel ﬁnding and highlights the way
in which patients draw on information from different
experiences and events to make a judgement on
whether or not a symptom requires medical care.31
The nature of cough has been discussed in the
context of those with lung cancer32 and we add to this
discussion by reporting the impact of cough on help-
seeking prior to diagnosis. The very public nature of a
chronic cough prompted members of the family and the
wider social network to encourage and endorse help-
seeking. The impact of cough on daily activities, such as
talking on the phone and shopping, also triggered
initial and subsequent help-seeking. Living alone has
been reported as a factor in prolonging help-seeking,9 33
but in line with an earlier interview study by Tod et al,34
we found that if the participant’s symptom was observed
by, or discussed with, family and friends, then timely
help-seeking often took place.
As we interviewed patients during a national ‘Be Clear
on Cancer’ lung cancer campaign16 we are able to
comment on the possible impact of the campaign on
patient’s symptom appraisal and help-seeking behaviour.
Some patients who had seen the campaign had a heigh-
tened awareness of respiratory symptoms, particularly a
persistent cough; for them the campaign endorsed the
need to seek help in line with ﬁndings from other studies
reporting the impact of similar health campaigns.17 18
However, in our study there were two patients who
reported that an increased awareness had slightly pro-
longed their help-seeking as they were concerned they
were over-reacting.
This is one of the ﬁrst studies to explicitly explore
patient processes during the time between ﬁrst consulting
a HCP, and further consultations leading to investigations
and referral. During the Re-appraisal Interval participants
continued to consider symptom change, severity and dur-
ation as triggers to return to the GP, but rarely reported
receiving guidance from their HCP on symptom monitor-
ing or when to reconsult. There were examples of substan-
tial time intervals between GP consultations.5 Those who
were given explicit advice on symptom monitoring and
when to return to the GP (so-called safety netting),35
promptly sought further consultations enabling GPs to
continue diagnostic investigations in a timely way. We
found some examples where patients with comorbidities
accessed regular healthcare but the HCP did not seem to
use the opportunity to follow-up on previously disclosed
symptoms suggestive of lung cancer.
Despite the evidence suggesting that people delay
help-seeking due to fear of cancer, we found that
patients were often unconcerned that symptoms may be
indicative of lung cancer even when they had increased
risk due to current or recent smoking habits.20 36 37 In
our study, concerns about candidacy for lung cancer
were only discussed within the context of reappraising
symptoms and when alternative explanations failed to
respond as expected to initial treatment.
Implications for clinicians and policymakers
Our ﬁndings provide further evidence for targeted
public health campaigns that are tailored to speciﬁc
groups such as smokers and people with other chest
conditions who may have difﬁcultly detecting symptom
change, focusing not only on recognition of new, chan-
ging and persistent symptoms but also on recognising
reduced effectiveness of medications. The role of family
and social networks in recognising and discussing a
symptom, and then endorsing help-seeking, could con-
tribute more prominently to public health initiatives to
raise community awareness of appropriate help-seeking
for timely diagnosis of lung cancer and other serious
lung conditions.
The vast majority of people who seek help for respira-
tory symptoms will not have lung cancer but our ﬁnd-
ings indicate that those with cancer and other
non-cancer diagnoses all undertake similar complex rea-
soning and decision-making when deciding whether and
when to seek help. There is a need for further research
into the ways in which people make these complex deci-
sions around assessing the seriousness and severity of
symptoms, the triggers to seek a medical consultation,
and their explanations about which symptoms can be
self-managed. Understanding the social context in which
risks of ill health are assessed would provide more oppor-
tunities for the development of targeted and evidence-
based interventions to promote timely help-seeking.
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Brindle and colleagues recently questioned whether
GP elicitation of normalised symptoms could reduce
delay in lung cancer diagnosis.13 Our ﬁndings conﬁrm
that GPs appear to miss opportunities, particularly
among people at higher risk such as smokers, ex-smokers
and those with chronic chest conditions; this may be due
to their gatekeeper role and current guidelines. While
acknowledging that the majority of patients presenting
with respiratory symptoms will not have lung cancer,
there nevertheless remains a need for vigilance and a sys-
tematic application of safety-netting procedures such as
explicit oral and written instructions detailing expected
symptom progression over time; recognition of changing,
persistent and new symptoms that should prompt a
further appointment; and a speciﬁed follow-up time.35
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